Bio-Path Holdings Files 2024 Annual Report
Ticker: BPTH · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
TL;DR
Bio-Path Holdings filed its 2024 10-K. Financials and operations detailed.
AI Summary
Bio-Path Holdings, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its operations and financial condition. The company, focused on pharmaceutical preparations, is based in Bellaire, TX. Key financial data and operational details for the period are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Bio-Path Holdings' financial performance and strategic direction for the past fiscal year, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Bio-Path Holdings faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 5767892 — Total Assets (Financial position as of December 31, 2024)
- 4.12 — Market Price per Share (Indicates current trading value)
- 33.63 — Market Capitalization (Overall market value of the company)
- 1700000 — Long-term Debt (Financial obligations beyond one year)
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-27 (date) — Filing date
- Bellaire, TX (location) — Company headquarters
- 4710 BELLAIRE BOULEVARD, SUITE 210 (address) — Company business and mail address
FAQ
What was Bio-Path Holdings' net income or loss for the fiscal year ended December 31, 2024?
The provided snippet does not explicitly state the net income or loss for the fiscal year ended December 31, 2024. Further review of the full 10-K document is required.
What is the company's primary business activity?
The company's Standard Industrial Classification (SIC) code is 2834, indicating its primary business is in Pharmaceutical Preparations.
When did Bio-Path Holdings, Inc. change its name from OGDEN GOLF CO CORP?
The name change from OGDEN GOLF CO CORP to BIO-PATH HOLDINGS INC occurred on 2001-02-05.
What significant financing events occurred in 2024?
The filing references a 'Registered Direct Offering' on 2024-03-27 and an 'April Registered Direct Offering' on 2024-04-19.
What is the maturity date for the company's debt?
The filing indicates a maturity date of 2037-12-31 for certain debt instruments.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding BIO-PATH HOLDINGS, INC. (BPTH).